Using Sugar Water to Relieve Pain in Infants
Effectiveness of Sucrose Analgesia in Reducing Pain Responses in Infants Born to Diabetic and Non-diabetic Mothers: A Randomized Controlled Trial
3 other identifiers
interventional
240
1 country
1
Brief Summary
This study will examine the safety and effectiveness of sugar water to relieve pain in newborn infants during painful blood tests and injections. Infants of diabetic mothers who receive repeated blood tests will be compared to infants of healthy mothers who receive routine painful procedures. We believe that administration of sucrose analgesia for every painful cutaneous procedure performed after delivery will result in less pain during the newborn infant screening test.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable pain
Started Jul 2003
Typical duration for not_applicable pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2003
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2005
CompletedFirst Submitted
Initial submission to the registry
September 13, 2005
CompletedFirst Posted
Study publicly available on registry
September 21, 2005
CompletedMarch 15, 2010
September 1, 2005
September 13, 2005
March 11, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
- Infant pain score during the newborn screening test, assessed by the Premature Infant Pain Profile (PIPP), or individual parameters of PIPP (facial grimace, heart rate, oxygen saturation)
Secondary Outcomes (9)
(effectiveness):
- Effectiveness of sucrose for repeated heel lances
- Effectiveness of sucrose in decreasing anticipatory pain responses during venipuncture
- Effectiveness of sucrose in decreasing pain response during Vitamin K injection
- Determination of relationship between painful procedures and infant response during routine care procedures
- +4 more secondary outcomes
Interventions
Eligibility Criteria
You may qualify if:
- healthy newborn infants ≥36 weeks gestation
- infants born to mothers with diabetes (type 1, type 2, or gestational diabetes that is diet-controlled or insulin-dependent)and infants born to mothers without diabetes
You may not qualify if:
- Admission to the neonatal intensive care unit
- plan to undergo circumcision during the study period
- major congenital or neurological anomalies
- clinical diagnosis of birth asphyxia or seizures
- receiving analgesics or sedatives
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Mount Sinai Hospital
Toronto, Ontario, M5G 1X5, Canada
Related Publications (1)
Taddio A, Shah V, Hancock R, Smith RW, Stephens D, Atenafu E, Beyene J, Koren G, Stevens B, Katz J. Effectiveness of sucrose analgesia in newborns undergoing painful medical procedures. CMAJ. 2008 Jul 1;179(1):37-43. doi: 10.1503/cmaj.071734.
PMID: 18591525DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Anna Taddio, PhD
The Hospital for Sick Children, Toronto Canada
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
September 13, 2005
First Posted
September 21, 2005
Study Start
July 1, 2003
Study Completion
July 1, 2005
Last Updated
March 15, 2010
Record last verified: 2005-09